Rapid non-genomic effects of aldosterone on the renal vasculature

Steroids

Volumn 73, Issue 9-10, 2008, Pages 961-965

  Schmidt, Bernhard M W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Aldosterone; Glomerular filtration rate; NO; Non genomic effects; Renal perfusion; Renal vascular resistance

Indexed keywords

ALDOSTERONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) METHYLARGININE; NITRIC OXIDE;

ARTICLE; GLOMERULUS FILTRATION RATE; HORMONE ACTION; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY VASCULAR RESISTANCE; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

ALDOSTERONE; ANIMALS; BLOOD FLOW VELOCITY; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MALE; MODELS, BIOLOGICAL; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; PERFUSION; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 44549083570     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.12.010     Document Type: Article

References (22)

1. Lim P.O., Rodgers P., Cardale K., Watson A.D., and MacDonald T.M. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 353 (1999) 40
2. Schmidt B.M.W., and Schmieder R.E. Aldosterone-induced cardiac damage: focus on blood pressure independent effects. Am J Hypertens 16 (2003) 80-86
3. Hollenberg N.K. Aldosterone in the development and progression of renal injury. Kidney Int 66 (2004) 1-9
4. Falkenstein E., Tillmann H.C., Christ M., Feuring M., and Wehling M. Multiple actions of steroid hormones-a focus on rapid, nongenomic effects. Pharmacol Rev 52 (2000) 513-556
5. Schmidt B.M.W., Gerdes D., Feuring M., Falkenstein E., Christ M., and Wehling M. Rapid, nongenomic steroid actions: a new age?. Front Neuroendocrinol 21 (2000) 57-94
6. Wehling M., Spes C.H., Win N., Janson C.P., Schmidt B.M.W., Theisen K., et al. Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 83 (1998) 3517-3522
7. Schmidt B.M.W., Montealegre A., Janson C.P., Martin N., Stein-Kemmesies C., Scherhag A., et al. Short term cardiovascular effects of aldosterone in healthy male volunteers. J Clin Endocrinol Metab 84 (1999) 3528-3533
8. Schmidt B.M.W., Georgens A.C., Martin N., Tillmann H.C., Feuring M., Christ M., et al. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system. J Clin Endocrinol Metab 86 (2001) 761-767
9. Klein K., and Henk W. Klinisch-experimentelle Untersuchungen über den Einfluß von Aldosteron auf Hämodynamik und Gerinnung. Z Kreislaufforsch 52 (1963) 40-53
10. Schmidt B.M.W., Oehmer S., Delles C., Bratke R., Schneider M.P., Klingbeil A., et al. Rapid nongenomic effects of aldosterone on human forearm vasculature. Hypertension 42 (2003) 156-160
11. Gunaruwan P., Schmitt M., Sharman J., Lee L., Struthers A., and Frenneaux M. Effects of aldosterone on forearm vasculature in treated chronic heart failure. Am J Cardiol 95 (2005) 412-414
12. Arima S., Kohagura K., Xu H.L., Sugawara A., Abe T., Satoh F., et al. Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol 14 (2003) 2255-2263
13. Arima S., Kohagura K., Xu H.L., Sugawara A., Uruno A., Satoh F., et al. Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole. Hypertension 43 (2004) 352-357
14. Uhrenholt T.R., Schjerning J., Hansen P.B., Norregaard R., Jensen B.L., Sorensen G.L., et al. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ Res 93 (2003) 1258-1266
15. Liu S.L., Schmuck S., Chorazcyzewski J.Z., Gros R., and Feldman R.D. Aldosterone regulates vascular reactivity: short-term effects mediated by phosphatidylinositol 3-kinase-dependent nitric oxide synthase activation. Circulation 108 (2003) 2400-2406
16. Skott O., Uhrenholt T.R., Schjerning J., Hansen P.B., Rasmussen L.E., and Jensen B.L. Rapid actions of aldosterone in vascular health and disease-friend or foe?. Pharmacol Ther 111 (2006) 495-507
17. Ribstein J., du C.G., Fesler P., and Mimran A. Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol 16 (2005) 1320-1325
18. Schmidt B.M.W., Sammer U., Fleischmann I., Schlaich M., Delles C., and Schmieder R.E. Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension 47 (2006) 650-655
19. Gomez D.M. Evaluation of renal resistances, with special reference to changes in essential hypertension. J Clin Invest 30 (1951) 1143-1155
20. Skov K., and Mulvany M.J. Structure of renal afferent arterioles in the pathogenesis of hypertension. Acta Physiol Scand 181 (2004) 397-405
21. Uhrenholt T.R., Schjerning J., Rasmussen L.E., Hansen P.B., Norregaard R., Jensen B.L., et al. Rapid non-genomic effects of aldosterone on rodent vascular function. Acta Physiol Scand 181 (2004) 415-419
22. 2+ levels and vasoconstriction in mesenteric resistance vessels. Endocrinology 146 (2004) 973-980